Current
$188B
5-Year Average
$200B
All-Time High
$253B
All-Time Low
$22B
Market cap daily chart for Abbott Laboratories (ABT)
Aug 2, 2021 – Jul 29, 2026 · 1,253 trading days
Market Cap growth chart for Abbott Laboratories (ABT) from 2017 to 2026
Latest: -14.0%
Market Cap history table for Abbott Laboratories (ABT) from 1985 to 2026
| 2026 | $188B | -14.0% | -$30.6B | ||
| 2025 | $219B | +10.7% | +$21.2B | ||
| 2024 | $198B | +2.7% | +$5.2B | ||
| 2023 | $193B | -0.6% | -$1.16B | ||
| 2022 | $194B | -23.1% | -$58.1B | ||
| 2021 | $252B | +28.8% | +$56.2B | ||
| 2020 | $196B | +26.4% | +$40.9B | ||
| 2019 | $155B | +20.8% | +$26.7B | ||
| 2018 | $128B | +28.3% | +$28.2B | ||
| 2017 | $99.8B | +75.2% | +$42.9B | ||
| 2016 | $57B | -15.8% | -$10.7B | ||
| 2015 | $67.6B | -1.6% | -$1.11B | ||
| 2014 | $68.7B | +13.9% | +$8.41B | ||
| 2013 | $60.3B | +20.9% | +$10.4B | ||
| 2012 | $49.9B | +18.1% | +$7.65B | ||
| 2011 | $42.2B | +18.4% | +$6.58B | ||
| 2010 | $35.7B | -11.2% | -$4.5B | ||
| 2009 | $40.2B | +0.8% | +$320M | ||
| 2008 | $39.8B | -4.9% | -$2.06B | ||
| 2007 | $41.9B | +17.0% | +$6.1B | ||
| 2006 | $35.8B | +21.4% | +$6.31B | ||
| 2005 | $29.5B | -15.9% | -$5.56B | ||
| 2004 | $35.1B | +6.5% | +$2.13B | ||
| 2003 | $32.9B | +16.4% | +$4.64B | ||
| 2002 | $28.3B | -27.9% | -$11B | ||
| 2001 | $39.3B | +15.1% | +$5.16B | ||
| 2000 | $34.1B | +34.1% | +$8.66B | ||
| 1999 | $25.4B | -26.0% | -$8.95B | ||
| 1998 | $34.4B | +48.3% | +$11.2B | ||
| 1997 | $23.2B | +28.5% | +$5.14B | ||
| 1996 | $18B | +20.9% | +$3.12B | ||
| 1995 | $14.9B | +25.3% | +$3.02B | ||
| 1994 | $11.9B | +7.8% | +$865M | ||
| 1993 | $11B | -3.4% | -$394M | ||
| 1992 | $11.4B | -13.1% | -$1.73B | ||
| 1991 | $13.2B | +50.9% | +$4.44B | ||
| 1990 | $8.73B | +30.2% | +$2.02B | ||
| 1989 | $6.7B | +38.7% | +$1.87B | ||
| 1988 | $4.83B | -1.3% | -$63.8M | ||
| 1987 | $4.9B | +2.7% | +$127M | ||
| 1986 | $4.77B | +33.5% | +$1.2B | ||
| 1985 | $3.57B | — | — |
- 2026$188B-14.0%
- 2025$219B+10.7%
- 2024$198B+2.7%
- 2023$193B-0.6%
- 2022$194B-23.1%
- 2021$252B+28.8%
- 2020$196B+26.4%
- 2019$155B+20.8%
- 2018$128B+28.3%
- 2017$99.8B+75.2%
- 2016$57B-15.8%
- 2015$67.6B-1.6%
- 2014$68.7B+13.9%
- 2013$60.3B+20.9%
- 2012$49.9B+18.1%
- 2011$42.2B+18.4%
- 2010$35.7B-11.2%
- 2009$40.2B+0.8%
- 2008$39.8B-4.9%
- 2007$41.9B+17.0%
- 2006$35.8B+21.4%
- 2005$29.5B-15.9%
- 2004$35.1B+6.5%
- 2003$32.9B+16.4%
- 2002$28.3B-27.9%
- 2001$39.3B+15.1%
- 2000$34.1B+34.1%
- 1999$25.4B-26.0%
- 1998$34.4B+48.3%
- 1997$23.2B+28.5%
- 1996$18B+20.9%
- 1995$14.9B+25.3%
- 1994$11.9B+7.8%
- 1993$11B-3.4%
- 1992$11.4B-13.1%
- 1991$13.2B+50.9%
- 1990$8.73B+30.2%
- 1989$6.7B+38.7%
- 1988$4.83B-1.3%
- 1987$4.9B+2.7%
- 1986$4.77B+33.5%
- 1985$3.57B—
Market Cap values are taken from Abbott Laboratories's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Abbott Laboratories (ABT)
According to Abbott Laboratories's latest reported financial statements, the company's latest reported market cap is $158B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2026, Abbott Laboratories (ABT) market cap totalled $188B – declined 14.0% year-over-year.
Looking at the 2021–2026 (5 years) stretch, Abbott Laboratories market cap compounded at -5.6% per year, with a net decline across the window.
Between 2021 and 2026, Abbott Laboratories market cap declined 25.2%, falling from $252B to $188B.
The record annual market cap stands at $252B, reached in 2021; the historical low of $3.57B was recorded in 1985.
Abbott Laboratories Market Cap by Year
Abbott Laboratories Market Cap 2026: $188B
Abbott Laboratories posted market cap of $188B in 2026, declined 14.0% below 2025.
Abbott Laboratories Market Cap 2025: $219B
In 2025, Abbott Laboratories reported market cap of $219B, grew 10.7% from 2024.
Abbott Laboratories Market Cap 2024: $198B
Abbott Laboratories market cap in 2024 was $198B, edged up 2.7% from 2023.
Abbott Laboratories Market Cap 2023: $193B
2023's market cap for Abbott Laboratories came in at $193B, edged down 0.6% below 2022.
Abbott Laboratories Market Cap 2022: $194B
Abbott Laboratories market cap in 2022 was $194B.
See more financial history for Abbott Laboratories (ABT).
Sector peers by Market Cap
Healthcare peers of Abbott Laboratories (ABT), ranked by their latest market cap
| $1.14T | |
| $640B | |
| $466B | |
| $382B | |
| $322B | |
| $229B | |
| $214B | |
| $209B |
- $1.14T
- $466B
- $322B
- $229B
- $209B
Frequently asked questions
Test yourself on ABT
Market Cap — 10 rounds, every one of them ABT against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Abbott Laboratories (ABT) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks1.16% TTM
- Dividend Profile2.30% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History9 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.